- About Us
- Health System in Slovakia
- Healthcare in 2020
- Slovenská verzia
2.9 Patient empowerment
|Introduction – Organization – Financing – Resources – Provision – Reforms – Assessment – Conclusions – Appendices||NEXT >>
3.1 Health expenditure
In 2009, total health expenditure as share of GDP was 7.6% according to national sources. This high GDP share was rather exceptional. Before 2009, the share was around 6.5% of GDP for three consecutive years. Slovak health insurance companies spend a relatively high share of their revenue on pharmaceuticals. Pharmaceutical expenditure amounts to 30% of expenditures by health insurance companies – compared to 7% on primary care, 11% on ambulatory secondary care and 27% on inpatient care.
Private VHI is part of the commercial insurance system. So far, private VHI plays only a marginal role due to the broad benefit package and low official cost-sharing requirements. According to the National Bank of Slovakia, total VHI premiums are approximately €1 million (in 2009). Thus they account for only 0.02% of total health expenditure and 0.2% of overall non-life insurance premiums.
Since Slovakia’s SHI system provides a broad range of benefits and universal coverage, the role of other sources of funding is rather limited. However, all employers must offer an occupational health service for employees working in high-risk environments since 2008.